This article is part of the supplement: Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference

Open Access Highly Accessed Proceedings

The basics of preclinical drug development for neurodegenerative disease indications

Karen L Steinmetz† and Edward G Spack†

BMC Neurology 2009, 9(Suppl 1):S2 doi:10.1186/1471-2377-9-S1-S2

Accesses  

  • Last 30 days: 566 accesses
  • Last 365 days: 6502 accesses
  • All time: 22400 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations